Industry Reports
Gilead Sciences to Acquire Kite Pharma for $11.9 Billion
Gilead Sciences, Inc. and Kite Pharma, Inc announced today that the companies have entered into a definitive agreement pursuant to which Gilead will acquire...
Clinical Trials
Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing
Blake Insomnia Therapeutics Inc. , a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is excited to...
Drug Research
AstraZeneca and Takeda establish collaboration to develop MEDI1341 for Parkinson’s disease
AstraZeneca and Takeda Pharmaceutical Company Limited announced that they have entered an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody currently in...
Press Releases
Clinerion releases revamped design with improved functionality for Patient Recruitment System.
Clinerion has redesigned the web application for Patient Recruitment System, creating a sleek, professional and intuitive new user interface with analytical capabilities. ...
Clinical Trials
Titan pharmaceuticals receives fda clearance to begin clinical study of parkinson’s disease treatment
Titan Pharmaceuticals, Inc. announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for its ropinirole implant intended for treatment of...
Clinical Trials
Symic Bio Enrolls First Patient in MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Osteoarthritis
Symic Bio, a biopharmaceutical company developing novel matrix regulators,announced the treatment of the first patient in the MODIFY2 Phase 2 clinical trial investigating SB-061...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read